DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the ...

Thursday, Abbott Laboratories ABT said it is recalling some FreeStyle Libre 3 sensors after finding ... Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients. This recall involves ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

Opens in a new tab or window The FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most ... an over-the-counter continuous glucose monitoring system, Lingo, for adults not on ...

Abbott Labs' key product line in its diabetes care segment is the FreeStyle Libre, a portfolio of continuous glucose monitoring (CGM ... CGM option for type 2 diabetes patients who do not use ...

A parenting expert has given five top tips to help parents adjust to a quieter household as millions of students prepare to ...

The FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most serious ... Abbott launched an over-the-counter ...

DexCom's newest G7 CGM competes closely with Abbott's FreeStyle ... MARD around 8.2% for G7. Wearable for 10.5 days and water-resistant up to 8ft for 24 hours. - Abbott Libre (Libre 2 and Libre ...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via ... People with type 2 diabetes can be offered it as an alternative to intermittently scanned of ...

The monitors - which Pharmac is now funding for all type 1 diabetics - mean patients are less likely to suffer early deaths, ...

Today, DexCom is the leading CGM company, with an estimated 40% market share. Importantly, CGM products are relatively nascent. DexCom generates nearly $4 billion in annual sales on a user base of ...

Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.